|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.050 USD | -0.44% |
|
-0.55% | +0.97% |
| 06-29 | Xilio Therapeutics, Inc.(NasdaqCM:XLO) added to Russell Microcap Value Benchmark Index | CI |
| 06-29 | Xilio Therapeutics, Inc. Announces Appointment of Ben Harshbarger as Chief Legal Officer | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.44% | -0.55% | -4.13% | +17.38% | +0.97% | -2.98% | -76.91% | - | - | 54.38M | |
| +0.90% | -2.33% | -3.27% | +14.52% | +4.39% | +0.68% | +14.52% | -21.85% | +205.94% | 48B | |
| +1.44% | +8.59% | +3.41% | +33.46% | +146.65% | +411.75% | +562.82% | +595.68% | - | 41.13B | |
| +3.66% | -4.55% | +14.73% | +33.94% | +4.83% | +28.47% | +7.75% | -4.88% | +203.81% | 37.56B | |
| +1.54% | +0.12% | +5.86% | +10.12% | +7.83% | +6.63% | +74.70% | -2.47% | +1,136.69% | 35.91B | |
| +2.42% | +7.27% | +3.65% | +1.02% | +10.40% | +14.90% | +44.79% | -14.11% | +160.39% | 29.86B | |
| -0.09% | -2.71% | -8.47% | +8.85% | - | - | - | - | - | 16.12B | |
| +2.14% | +0.14% | +3.66% | +36.12% | +4.29% | +34.26% | +124.95% | +225.15% | - | 16.05B | |
| +1.25% | +1.52% | +1.43% | +18.62% | +11.67% | +4.62% | +18.66% | -38.05% | +80.21% | 13.76B | |
| +4.20% | -8.09% | -4.20% | +34.98% | -10.13% | -1.34% | -34.90% | -32.76% | +114.23% | 12.1B | |
| +10.52% | +10.33% | +11.94% | +39.74% | +29.87% | +54.67% | +26.20% | -36.81% | +202.22% | 11.28B | |
| -0.05% | -0.01% | +1.56% | +27.07% | +22.47% | +31.82% | -11.40% | -41.28% | +155.82% | 11.23B | |
| +0.37% | +0.65% | -15.36% | +3.41% | -9.39% | +81.83% | +562.01% | +294.58% | +2,385.19% | 10.79B | |
| -0.02% | -0.03% | +0.50% | +61.08% | +77.75% | +250.03% | +554.46% | - | - | 10.07B | |
| +0.10% | +5.94% | +35.14% | +36.34% | +40.56% | +34.05% | +36.06% | -60.42% | - | 9.85B | |
| -2.06% | +0.06% | -34.99% | -28.14% | -31.65% | +25.61% | +38.23% | +37.32% | +49.71% | 9.15B | |
| -1.57% | -0.24% | +6.54% | +22.68% | -11.89% | -20.67% | -17.36% | -29.17% | +33.52% | 8.75B | |
| +0.10% | +2.37% | +3.54% | +37.23% | +55.89% | +152.60% | +619.23% | +182.53% | - | 8.73B | |
| +2.28% | +9.21% | +1.38% | -4.64% | +7.83% | +565.03% | +2,195.56% | +43.84% | - | 8.64B | |
| +0.25% | -0.72% | -8.94% | +26.34% | +34.30% | +143.18% | +420.39% | +67.81% | - | 8.59B | |
| Average | +1.34% | -0.48% | +0.70% | +21.51% | +20.88% | +95.53% | +271.57% | +68.54% | +429.79% | 17.38B | |
| Weighted average by Cap. | +1.60% | -0.66% | +2.26% | +21.17% | +27.90% | +95.10% | +212.23% | +92.71% | +420.98% |
- Stock Market
- Stocks
- XLO Stock
- Sector Xilio Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
